In the breast cancer model, the protein Morgana—ubiquitously expressed and pivotal for embryonic development as well as tumorigenesis—has been shown to amplify NF-κB activation, thereby enhancing the recruitment of NK cells and other immune cells to the TME (18, 19). Here, NFKB1 is linked to breast carcinoma.